Guardant Health, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +39.6%
EBITDA: -5.5%
EBIT: +1.6%
EPS: +0.0%
Free cash flow: +26.3%
Operating cash flow: +35.6%

Forward estimates

Revenue: +33.8%
EBITDA: —
EPS: +31.5%

Three-year CAGR

Revenue: +29.8%
EBITDA: +4.2%
EBIT: +1.6%
Net income: +4.6%
EPS: +6.7%
Free cash flow: +15.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.